Skip to NavigationSkip to content

News

0
The FDA has given the regulatory thumbs-up in the US of Reblozyl (luspatercept-aamt), the “first and only erythroid maturation agent” according to...
0
Gaza is at huge risk from the coronavirus pandemic due to years of living under a blockade from Israel which has crippled its infrastructure and...
0
Matt Hancock, the UK’s Health Secretary, has said that more patients with the COVID-19 coronavirus are need in clinical trials testing licensed drugs...
0
The European Commission has greenlighted Novo Nordisk’s Rybelsus (oral semaglutide) as an adjunct to diet and exercise to improve glycaemic control...

Features

Every year, Veeva asks clinical professionals to take part in the Veeva Unified Clinical Operations Survey to help the industry better...